The Recruitment Innovation Center: Developing novel, person-centered strategies for clinical trial recruitment and retention

Abstract Clinical trials continue to face significant challenges in participant recruitment and retention. The Recruitment Innovation Center (RIC), part of the Trial Innovation Network (TIN), has been funded by the National Center for Advancing Translational Sciences of the National Institutes of Health to develop innovative strategies and technologies to enhance participant engagement in all stages of multicenter clinical trials. In collaboration with investigator teams and liaisons at Clinical and Translational Science Award institutions, the RIC is charged with the mission to design, field-test, and refine novel resources in the context of individual clinical trials. These innovations are disseminated via newsletters, publications, a virtual toolbox on the TIN website, and RIC-hosted collaboration webinars. The RIC has designed, implemented, and promised customized recruitment support for 173 studies across many diverse disease areas. This support has incorporated site feasibility assessments, community input sessions, recruitment materials recommendations, social media campaigns, and an array of study-specific suggestions. The RIC’s goal is to evaluate the efficacy of these resources and provide access to all investigating teams, so that more trials can be completed on time, within budget, with diverse participation, and with enough accrual to power statistical analyses and make substantive contributions to the advancement of healthcare.

[1]  Rebecca N. Jerome,et al.  Engaging smokers in research: Utility of Facebook in facilitating recruitment to a smoking cessation study. , 2021, Contemporary clinical trials.

[2]  Terri L. Edwards,et al.  Creating and implementing a COVID-19 recruitment Data Mart , 2021, Journal of Biomedical Informatics.

[3]  Sheila V. Kusnoor,et al.  Design and implementation of a massive open online course on enhancing the recruitment of minorities in clinical trials – Faster Together , 2021, BMC Medical Research Methodology.

[4]  Adrian F. Hernandez,et al.  Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial , 2021, Trials.

[5]  Rebecca N. Jerome,et al.  Opening doors to clinical trial participation among Hispanics: Lessons learned from the Spanish translation of ResearchMatch , 2020, Journal of Clinical and Translational Science.

[6]  Paul A. Harris,et al.  A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent , 2020, Journal of Clinical and Translational Science.

[7]  D. Schlundt,et al.  Assessing research participant preferences for receiving study results , 2019, Journal of Clinical and Translational Science.

[8]  Rebecca N. Jerome,et al.  To end disease tomorrow, begin with trials today: Digital strategies for increased awareness of a clinical trials finder , 2019, Journal of Clinical and Translational Science.

[9]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[10]  Rebecca N. Jerome,et al.  Understanding What Information Is Valued By Research Participants, And Why. , 2019, Health affairs.

[11]  C. Wilkins Effective Engagement Requires Trust and Being Trustworthy , 2018, Medical care.

[12]  Rebecca N. Jerome,et al.  Connecting the public with clinical trial options: The ResearchMatch Trials Today tool , 2018, Journal of Clinical and Translational Science.

[13]  Emily R. Busta,et al.  Principles for the Return of Individual Research Results: Ethical and Societal Considerations , 2018 .

[14]  Grant D. Huang,et al.  Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative. , 2018, Contemporary clinical trials.

[15]  Sarah R Lewis,et al.  The Practice of Health Program Evaluation , 2017, Health promotion practice.

[16]  Tiina K. Urv,et al.  Early Vision for the CTSA Program Trial Innovation Network: A Perspective from the National Center for Advancing Translational Sciences , 2017, Clinical and translational science.

[17]  Stephanie Devaney,et al.  A Survey of U.S Adults’ Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment , 2016, PloS one.

[18]  G. Bernard,et al.  Community Engagement Studios: A Structured Approach to Obtaining Meaningful Input From Stakeholders to Inform Research , 2015, Academic medicine : journal of the Association of American Medical Colleges.

[19]  Nina S. Parikh,et al.  Examining Barriers and Practices to Recruitment and Retention in Stroke Clinical Trials , 2015, Stroke.

[20]  Tim Ramsay,et al.  Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials , 2015, Clinical trials.

[21]  W. McCaskill-Stevens,et al.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. , 2013, Journal of oncology practice.

[22]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[23]  Lois Lamerato,et al.  Recruitment methods employed in the prostate, lung, colorectal, and ovarian cancer screening trial , 2009, Clinical trials.

[24]  F. Miller,et al.  Disclosing individual results of clinical research: implications of respect for participants. , 2005, JAMA.

[25]  B. Meibohm,et al.  Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. , 2004, International journal of clinical pharmacology and therapeutics.

[26]  W. Frishman,et al.  Gender, ethnicity and genetics in cardiovascular disease: part 1: Basic principles. , 2003, Heart disease.

[27]  D. Hunninghake,et al.  Recruitment for controlled clinical trials: literature summary and annotated bibliography. , 1997, Controlled clinical trials.

[28]  J. Kestle Clinical Trials , 2014, World Journal of Surgery.

[29]  S. Clarke,et al.  Ethnic differences in drug metabolism and toxicity from chemotherapy. , 2009, Expert opinion on drug metabolism & toxicology.